As of 2026-07-02, the Relative Valuation of Pfizer Inc (PFE) is 28.55 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.08 USD, the upside of Pfizer Inc based on Relative Valuation is 18.6%.
The range of the Relative Valuation is 23.30 - 42.32 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 32.2x | 24.8x |
| Forward P/E multiples | 17.4x - 19.5x | 18.3x |
| Fair Price | 23.30 - 42.32 | 28.55 |
| Upside | -3.2% - 75.8% | 18.6% |
| Date | P/E |
| 2026-06-30 | 18.32 |
| 2026-06-29 | 18.54 |
| 2026-06-26 | 18.48 |
| 2026-06-25 | 18.01 |
| 2026-06-24 | 18.29 |
| 2026-06-23 | 18.81 |
| 2026-06-22 | 19.08 |
| 2026-06-18 | 19.18 |
| 2026-06-17 | 19.72 |
| 2026-06-16 | 19.81 |
| 2026-06-15 | 19.78 |
| 2026-06-12 | 19.94 |
| 2026-06-11 | 19.91 |
| 2026-06-10 | 19.48 |
| 2026-06-09 | 19.55 |
| 2026-06-08 | 19.49 |
| 2026-06-05 | 19.81 |
| 2026-06-04 | 19.55 |
| 2026-06-03 | 19.28 |
| 2026-06-02 | 19.44 |
| 2026-06-01 | 19.50 |
| 2026-05-29 | 19.92 |
| 2026-05-28 | 19.89 |
| 2026-05-27 | 19.94 |
| 2026-05-26 | 19.67 |
| 2026-05-22 | 19.71 |
| 2026-05-21 | 19.74 |
| 2026-05-20 | 19.62 |
| 2026-05-19 | 19.52 |
| 2026-05-18 | 19.27 |
| 2026-05-15 | 19.27 |
| 2026-05-14 | 19.59 |
| 2026-05-13 | 19.75 |
| 2026-05-12 | 19.68 |
| 2026-05-11 | 19.64 |
| 2026-05-08 | 19.54 |
| 2026-05-07 | 20.15 |
| 2026-05-06 | 20.19 |
| 2026-05-05 | 20.12 |
| 2026-05-04 | 20.01 |
| 2026-05-01 | 20.03 |
| 2026-04-30 | 20.31 |
| 2026-04-29 | 19.98 |
| 2026-04-28 | 20.15 |
| 2026-04-27 | 20.38 |
| 2026-04-24 | 20.54 |
| 2026-04-23 | 20.29 |
| 2026-04-22 | 20.39 |
| 2026-04-21 | 20.78 |
| 2026-04-20 | 20.94 |